These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16914349)

  • 1. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
    Fonseca CT; Pacífico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC
    Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway.
    Fonseca CT; Brito CF; Alves JB; Oliveira SC
    Vaccine; 2004 Jan; 22(3-4):503-10. PubMed ID: 14670333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
    Varaldo PB; Leite LC; Dias WO; Miyaji EN; Torres FI; Gebara VC; Armôa GR; Campos AS; Matos DC; Winter N; Gicquel B; Vilar MM; McFadden J; Almeida MS; Tendler M; McIntosh D
    Infect Immun; 2004 Jun; 72(6):3336-43. PubMed ID: 15155638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
    Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Oliveira SC
    Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein.
    Brito CF; Caldas IR; Coura Filho P; Correa-Oliveira R; Oliveira SC
    Scand J Immunol; 2000 Jun; 51(6):595-601. PubMed ID: 10849370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.
    Garcia TC; Fonseca CT; Pacifico LG; Durães Fdo V; Marinho FA; Penido ML; Caliari MV; de Melo AL; Pinto HA; Barsante MM; Cunha-Neto E; Oliveira SC
    Acta Trop; 2008 Jun; 106(3):162-7. PubMed ID: 18423420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice.
    Varaldo PB; Miyaji EN; Vilar MM; Campos AS; Dias WO; Armôa GR; Tendler M; Leite LC; McIntosh D
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):132-9. PubMed ID: 16965361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with Salmonella harboring a Sm14-based DNA vaccine does not protect mice against Schistosoma mansoni infection.
    Pacheco LG; Mati VL; Castro TL; Dorella FA; Oliveira SC; Miyoshi A; de Melo AL; Azevedo V
    Parasitol Int; 2008 Dec; 57(4):506-8. PubMed ID: 18538627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
    PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection.
    Espíndola MS; Frantz FG; Soares LS; Masson AP; Tefé-Silva C; Bitencourt CS; Oliveira SC; Rodrigues V; Ramos SG; Silva CL; Faccioli LH
    BMC Infect Dis; 2014 May; 14():263. PubMed ID: 24886395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
    Ramos CR; Spisni A; Oyama S; Sforça ML; Ramos HR; Vilar MM; Alves AC; Figueredo RC; Tendler M; Zanchin NI; Pertinhez TA; Ho PL
    Biochim Biophys Acta; 2009 Apr; 1794(4):655-62. PubMed ID: 19150418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased immunogenicity and protection of recombinant Sm14 antigens by heat-killed Cutibacterium acnes in BALB/c mice infected with Schistosoma mansoni.
    Lam HYP; Huang SP; Liang TR; Wu WJ; Cheng PC; Chang KC; Peng SY
    Parasitol Int; 2022 Feb; 86():102446. PubMed ID: 34481947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses against Schistosoma japonicum after vaccinating mice with a multivalent DNA vaccine encoding integrated membrane protein Sj23 and cytokine interleukin-12.
    Gan Y; Shi YE; Bu LY; Zhu XH; Ning CX; Zhu HG
    Chin Med J (Engl); 2004 Dec; 117(12):1842-6. PubMed ID: 15603716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination of mice with recombinant nucleic acid vaccine encoding the integral membrane protein Sj23 and cytokine IL-12 elicits specific immune responses against schistosoma japonica].
    Gan Y; Shi YE; Bu LY; Ning CX; Zhu HG
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):193-8. PubMed ID: 15854467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.
    Abreu PA; Miyasato PA; Vilar MM; Dias WO; Ho PL; Tendler M; Nascimento AL
    Infect Immun; 2004 Oct; 72(10):5931-7. PubMed ID: 15385496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
    Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
    Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
    Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
    Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosoma mansoni schistosomula tegument (Smteg) immunization in absence of adjuvant induce IL-10 production by CD4+ cells and failed to protect mice against challenge infection.
    Araujo JM; de Melo TT; de Sena IC; Alves CC; Araujo N; Durães Fdo V; Oliveira SC; Fonseca CT
    Acta Trop; 2012 Nov; 124(2):140-6. PubMed ID: 22842304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
    Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.